vida: research 2026 04 28 #4655

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 09:26:50 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 09:27 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 09:27 UTC*
Member
  1. Factual accuracy — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context, which aligns with general market knowledge.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely.
  3. Confidence calibration — The confidence calibration for Belief 4 being "SIGNIFICANTLY STRENGTHENED" is appropriate given the direct commercial outcomes presented as empirical validation.
  4. Wiki links — There are no wiki links present in the research-journal.md file.
1. **Factual accuracy** — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context, which aligns with general market knowledge. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely. 3. **Confidence calibration** — The confidence calibration for Belief 4 being "SIGNIFICANTLY STRENGTHENED" is appropriate given the direct commercial outcomes presented as empirical validation. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema: All files in this PR are either research journal entries (agents/vida/) or sources (inbox/queue/) — no claims or entities are being modified, so schema validation for claims/entities does not apply; the research journal follows the established freeform format for agent logs, and source files in inbox/queue/ are correctly placed for future claim extraction.

2. Duplicate/redundancy: This is a research journal entry documenting a new investigation session (2026-04-28) with nine supporting source files; no claims are being enriched in this PR, so there is no risk of injecting duplicate evidence into existing claims — this is net-new research documentation.

3. Confidence: No claims are being modified or created in this PR (only research journal documentation and source ingestion), so confidence calibration does not apply at this stage.

4. Wiki links: The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken wiki links to KB claims; no actual bracketed links are present in the diff.

5. Source quality: The nine source files reference credible entities (WeightWatchers bankruptcy, Omada Health IPO, Noom product launches, employer coverage data from PHTI) that are verifiable through public financial filings and health industry reporting — these are appropriate sources for future claim development.

6. Specificity: No claims are being created or modified in this PR; the research journal contains specific falsifiable observations (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") that will presumably be extracted into properly structured claims in future PRs.

Verdict reasoning: This PR documents a research session and ingests supporting sources without modifying any claims or entities in the knowledge base. The research journal entry follows the established format for agent documentation, contains specific factual observations with named sources, and the nine accompanying source files are appropriately placed in inbox/queue/ for future claim extraction. No schema violations, no confidence miscalibrations, no duplicate evidence injection — this is standard research documentation workflow.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/) or sources (inbox/queue/) — no claims or entities are being modified, so schema validation for claims/entities does not apply; the research journal follows the established freeform format for agent logs, and source files in inbox/queue/ are correctly placed for future claim extraction. **2. Duplicate/redundancy:** This is a research journal entry documenting a new investigation session (2026-04-28) with nine supporting source files; no claims are being enriched in this PR, so there is no risk of injecting duplicate evidence into existing claims — this is net-new research documentation. **3. Confidence:** No claims are being modified or created in this PR (only research journal documentation and source ingestion), so confidence calibration does not apply at this stage. **4. Wiki links:** The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken [[wiki links]] to KB claims; no actual [[bracketed links]] are present in the diff. **5. Source quality:** The nine source files reference credible entities (WeightWatchers bankruptcy, Omada Health IPO, Noom product launches, employer coverage data from PHTI) that are verifiable through public financial filings and health industry reporting — these are appropriate sources for future claim development. **6. Specificity:** No claims are being created or modified in this PR; the research journal contains specific falsifiable observations (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") that will presumably be extracted into properly structured claims in future PRs. **Verdict reasoning:** This PR documents a research session and ingests supporting sources without modifying any claims or entities in the knowledge base. The research journal entry follows the established format for agent documentation, contains specific factual observations with named sources, and the nine accompanying source files are appropriately placed in inbox/queue/ for future claim extraction. No schema violations, no confidence miscalibrations, no duplicate evidence injection — this is standard research documentation workflow. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 09:28:36 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 09:28:36 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 09:30:44 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.